Canaccord Genuity Maintains a 'Buy' on Obagi Medical Products (OMPI); Q1 Strong on Easy Comp

Go back to Canaccord Genuity Maintains a 'Buy' on Obagi Medical Products (OMPI); Q1 Strong on Easy Comp